Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Adeno-associated viral vector serotype 2/2 containing a gene encoding the channelrhodopsin-2 protein

EU orphan designation number: EU/3/16/1740   
Active ingredient: Adeno-associated viral vector serotype 2/2 containing a gene encoding the channelrhodopsin-2 protein
Indication: Treatment of retinitis pigmentosa
Sponsor: Allergan Pharmaceuticals International Limited
Clonshaugh Industrial Estate, Coolock, Dublin 17, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/10/2016 Orphan designation EMA/OD/158/16 (2016)6731 of 14/10/2016
7/09/2017 Transfer of orphan designation EMA/OD/158/16/T/01 (2017)6105 of 5/09/2017